Tandem Diabetes Care Inc (NASDAQ: TNDM) stock enjoyed a major increase of 12.2% on 10/3/25. The shares closed at $14.71. Trading volume in this advance was normal. The stock has been extremely weak relative to the market over the last nine months but has risen 23.0% during the last week.
Current PriceTarget Research Rating
Tandem Diabetes Care has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Tandem Diabetes Care has a very low Appreciation Score of 14 and a very low Power Rating of 2, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment